suPAR abstract wins 1. prize at DEMC7 Emergency Conference

Thu Dec 01 2016

The abstract “suPAR as a standard prognostic test in the Acute Medical Unit at Hvidovre Hospital”was selected for an oral presentation, and won 1. prize at DEMC7 in Copenhagen, the biggest Emergency Medicine Conference in northern Europe, on November 25.

Line Jee Hartmann Rasmussen from Hvidovre Hospital presented her data  on 17.312 acute medical patients measured with suPAR, to verify the prognostic value of suPAR with regard to readmission and survival.

The conclusion is, that high suPAR was associated with 
– Increased number and severity of comorbidities
– Longer admission time
– High readmission rate– High mortality rate

suPAR remained an independent predictor after adjustment for age, sex, Charlson score, and CRP.

Please find the poster on Lines abstract here

+800

published suPAR studies in leading medical journals

Nature Medicine Logo
Science Journal Logo
JAMA Pediatrics Logo

The suPARnostic® brand consists of 3 products:

Photo of The suPARnostic® Quick Triage kit

Quick Triage

A Point of Care Solution

Photo of suPARnostic® TurbiLatex

TurbiLatex

For Automated Systems

Photo of suPARnostic® ELISA

ELISA Assay

Clinical and Research

suPAR is used in clinical routine in 38 hospitals

38 hospitals use suPAR in clinical routine for triage of patients in the Emergency Departments and COVID-19 units. Clinical routine is defined by the placement of two Purchasing Orders within the last 12 months rolling. This period covers October 1, 2021, until September 30, 2022.
Some hospital locations cannot be disclosed due to confidentiality.

New Webinar

Webinar

Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates